Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In 2002, we reported the initial results of a trial comparing radical prostatectomy with watchful waiting in the management of early prostate cancer. After three more years of follow-up, we report estimated 10-year results. METHODS: From October 1989 through February 1999, 695 men with early prostate cancer (mean age, 64.7 years) were randomly assigned to radical prostatectomy (347 men) or watchful waiting (348 men). The follow-up was complete through 2003, with blinded evaluation of the causes of death. The primary end point was death due to prostate cancer; the secondary end points were death from any cause, metastasis, and local progression. RESULTS: During a median of 8.2 years of follow-up, 83 men in the surgery group and 106 men in the watchful-waiting group died (P=0.04). In 30 of the 347 men assigned to surgery (8.6 percent) and 50 of the 348 men assigned to watchful waiting (14.4 percent), death was due to prostate cancer. The difference in the cumulative incidence of death due to prostate cancer increased from 2.0 percentage points after 5 years to 5.3 percentage points after 10 years, for a relative risk of 0.56 (95 percent confidence interval, 0.36 to 0.88; P=0.01 by Gray's test). For distant metastasis, the corresponding increase was from 1.7 to 10.2 percentage points, for a relative risk in the surgery group of 0.60 (95 percent confidence interval, 0.42 to 0.86; P=0.004 by Gray's test), and for local progression, the increase was from 19.1 to 25.1 percentage points, for a relative risk of 0.33 (95 percent confidence interval, 0.25 to 0.44; P<0.001 by Gray's test). CONCLUSIONS: Radical prostatectomy reduces disease-specific mortality, overall mortality, and the risks of metastasis and local progression. The absolute reduction in the risk of death after 10 years is small, but the reductions in the risks of metastasis and local tumor progression are substantial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the “gold standard” treatments for early stage prostate cancer is radical prostatectomy (RP), which has established long-term benefit (2-5).”
From Men's experience with penile rehabilitation following radical prostatectomy: a qualitative study with the goal of informing a therapeutic intervention. (2015) · cites this paper as [2]
Citations
Cites
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
Self-citationA Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate Cancer
Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Häggman, M., Andersson, S.-O., Spångberg, A., Busch, C., Nordling, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012794 · Cited by 817
Self-citationQuality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Self-citationNatural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
Self-citationPotosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
The role of radical prostatectomy in the management of prostatic cancer
Walsh, P. C., & Lepor, H. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<526::aid-cncr2820601515>3.0.co;2-9 · Cited by 131
Carcinoma of the prostate. Hormonal therapy
Grayhack, J. T., Keeler, T. C., & Kozlowski, J. M. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+<589::aid-cncr2820601526>3.0.co;2-r · Cited by 111
Staging Pelvic Lymphadenectomy for Carcinoma of the Prostate: Risk Versus Benefit
Brendler, C. B., Cleeve, L. K., Anderson, E. E., & Paulson, D. F. (1980) · The Journal of Urology · doi:10.1016/s0022-5347(17)55696-7 · Cited by 106
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden
Johansson, J.-E. (1997) · JAMA · doi:10.1001/jama.277.6.467 · Cited by 102
Self-citation
Research works printed but not linked: 1
- 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T · doi:10.1002/1097-0142(19930715)72:2<310::aid-cncr2820720203>3.0.co;2-t
Cited by
Items 601–700 of 999
What is the value of screening for prostate cancer in the US?
Albertsen, P. C. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0348 · Cited by 11
Le dépistage du cancer de la prostate : hétérogénéités des recommandations
Gignon, M., Braillon, A., Chaine, F.-X., & Dubois, G. (2007) · Canadian Journal of Public Health · doi:10.1007/bf03403715 · Cited by 11
What is the best approach for screen-detected low volume cancers?—The case for observation
Klotz, L. H. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.03.003 · Cited by 11
Evidence-Based Medicine, Conscience-Based Medicine, and the Management of Low-Risk Prostate Cancer
Zietman, A. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.4533 · Cited by 11
Cancer screening in older adults: What to do when we don't know
Alibhai, S. M. H., & Horgan, A. M. (2011) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2011.03.004 · Cited by 11
Koupparis, A. J., Grummet, J., Hurtado‐Coll, A., Bell, R. H., Buchan, N. C., Goldenberg, S. L., & Gleave, M. E. (2011) · Canadian Urological Association Journal · doi:10.5489/cuaj.10057 · Cited by 12
Optimization of the Radiation Management of High-Risk Prostate Cancer
Nguyen, P. L. (2016) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2016.08.009 · Cited by 10
Aktive Überwachung des Prostatakarzinoms
Graefen, M., Ahyai, S., Heuer, R., Salomon, G., Schlomm, T., Hendrik Isbarn, A., Budäus, L., Hans Heinzer, A., & Huland, H. (2008) · Der Urologe · doi:10.1007/s00120-008-1638-0 · Cited by 10
Nakayama, A., Ide, H., Lü, Y., Takei, A., Fukuda, K., Osaka, A., Arai, G., Horie, S., Okada, H., & Saito, K. (2021) · In Vivo · doi:10.21873/invivo.12396 · Cited by 11
Zhou, J., Zhang, F., Hou, X. S., & Zhang, N. (2014) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2014.1661 · Cited by 13
Pickles, T., Morgan, S. C., Morton, G., Souhami, L., Warde, P. R., & Lukka, H. R. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.467 · Cited by 10
Sartor, O. A., McLeod, D. G., Halabi, S., Schellhammer, P. F., Scardino, P. T., D'Amico, A. V., Bennett, C. L., & Wei, J. T. (2009) · Urology · doi:10.1016/j.urology.2009.04.059 · Cited by 10
Hashimoto, T., Nakashima, J., Inoue, R., Komori, O., Yamaguchi, Y., Kashima, T., Satake, N., Nakagami, Y., Namiki, K., Nagao, T., et al. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01561-4 · Cited by 10
Brooks, J. D., Tibshirani, R. J., Ferrari, M. K., Presti, J. C., Gill, H. S., & King, C. R. (2008) · The Open Prostate Cancer Journal · doi:10.2174/1876822900801010001 · Cited by 10
Technical advances in urological laparoscopic surgery
Hafron, J. M., & Kaouk, J. H. (2008) · Expert Review of Medical Devices · doi:10.1586/17434440.5.2.145 · Cited by 10
Dysfonction érectile après prostatectomie totale : physiopathologie, évaluation et traitement
Audouin, M., Beley, S., Cour, F., Vaessen, C., Chartier-Kastler, E. J., Bitker, M., Richard, F., & Morgan Rouprêt, A. (2009) · The French Journal of Urology · doi:10.1016/j.purol.2009.06.008 · Cited by 10
Gaztañaga, M., & Crook, J. M. (2012) · Brachytherapy · doi:10.1016/j.brachy.2012.04.006 · Cited by 11
Azancot, V., Peyromaure, M., Xylinas, E. N., Descazeaud, A., Cornud, F., Vieillefond, A., Saighi, D., Amsellem‐Ouazana, D., Debré, B., & Zerbib, M. (2009) · The French Journal of Urology · doi:10.1016/j.purol.2009.05.011 · Cited by 10
The changing face of hormonal therapy for prostate cancer
Šeruga, B., & Tannock, I. F. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn477 · Cited by 11
Erectile Dysfunction after Radical Prostatectomy: Treatment Options
Glina, S. (2011) · Drugs & Aging · doi:10.2165/11588290-000000000-00000 · Cited by 14
Pelvine Lymphadenektomie und radikale Prostatektomie
Grimm, M., Thomas, C., Fröhner, M., Wiegel, T., Heidenreich, A., Thüroff, J., & Wirth, M. (2010) · Der Urologe · doi:10.1007/s00120-010-2237-4 · Cited by 10
Roddam, A., Hamdy, F. C., Allen, N. E., Price, C. P., & for the UK Prostate Cancer Risk Management Programme (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07000.x · Cited by 10
Does current evidence justify prostate cancer screening in Europe?
Martin, R. M., Smith, G. D., & Donovan, J. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0349 · Cited by 10
Taverna, G., Benecchi, L., Grizzi, F., Seveso, M., Giusti, G., Piccinelli, A., Benetti, A., Colombo, P., Minuti, F., & Graziotti, P. (2012) · Journal of Oncology · doi:10.1155/2012/645146 · Cited by 9
Sieswerda, M. S., Xie, S., van Rossum, R., Bermejo, I., Geleijnse, G., Aben, K. K. H., van Erning, F. N., Lemmens, V. E. P. P., Dekker, A. L. A. J., & Verbeek, X. A. A. M. (2023) · JCO Clinical Cancer Informatics · doi:10.1200/cci.22.00080 · Cited by 11
Yoo, D. S., Wong, T. Z., & Brizel, D. M. (2010) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2010.10.002 · Cited by 9
Drouin, S., Compérat, É., Cussenot, O., Bitker, M., Haertig, A., & Morgan Rouprêt, A. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.04.004 · Cited by 9
Tang, P., Sun, L. L., Uhlman, M. A., Robertson, C. N., Polascik, T. J., Albala, D. M., Donatucci, C. F., & Moul, J. W. (2009) · Urology · doi:10.1016/j.urology.2009.09.049 · Cited by 9
Lee, Y. I., Lee, H. M., Jo, J. K., Lee, S., Hong, S. K., Byun, S., Lee, S. E., & Oh, J. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148690 · Cited by 11
Sood, A., Grauer, R., Diaz‐Insua, M., Tewari, A. K., Hemal, A. K., Shrivastava, A., Peabody, J. O., Jeong, W., Abdollah, F., Rudzinski, J. K., et al. (2023) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-023-00674-2 · Cited by 9
Low-dose rate brachytherapy of the prostate in elderly patients
Chiumento, C., Fiorentino, A., Caivano, R., Clemente, S., & Fusco, V. (2012) · La radiologia medica · doi:10.1007/s11547-012-0872-0 · Cited by 9
Risk Communication and Prostate Cancer
Ilić, D., Murphy, K., & Green, S. (2012) · American Journal of Men s Health · doi:10.1177/1557988312453616 · Cited by 9
Rubio‐Briones, J., Iborra, I., Trassierra, M., Collado, A., Casanova, J., Gomez-Ferrer, A., Ricós, J. V., Monrós, J. L., Dumont, R., & Solsona, E. (2010) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2010.03.029 · Cited by 9
Shifting focus to cancer survivorship in prostate cancer: challenges and opportunities
Gilbert, S. M. (2008) · Current Opinion in Urology · doi:10.1097/mou.0b013e3282f9b3ff · Cited by 12
Chu, P. G., Lau, S. K., Weiss, L. M., Kawachi, M. H., Yoshida, J. S., Ruel, C., Nelson, R. A., Crocitto, L. E., & Wilson, T. G. (2008) · Surgical Endoscopy · doi:10.1007/s00464-008-0131-6 · Cited by 9
Vargas, C., Swartz, D. A., VASHI, A. R., Blasser, M. H., Kasareian, A., Cesaretti, J. A., Kiley, K., & Terk, M. (2012) · Brachytherapy · doi:10.1016/j.brachy.2012.08.002 · Cited by 9
Focal therapy for prostate cancer: Fact or fiction?
Lecornet, E., Moore, C. M., Ahmed, H. U., & Emberton, M. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.08.004 · Cited by 9
Lin, A., & Small, E. J. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f8b075 · Cited by 9
Regional differences in recommended cancer treatment for the elderly
Ho, V., Ku‐Goto, M., Zhao, H., Hoffman, K. E., Smith, B. D., & Giordano, S. H. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1534-z · Cited by 9
Biochemical recurrence‐free conditional probability after radical prostatectomy: A dynamic prognosis
Barreras, S. G., Sánchez-Salas, R., Mejía-Monasterio, C., Muttin, F., Secin, F. P., Dell’Oglio, P., Nunes‐Silva, I., Srougi, V., Barret, É., Rozet, F., et al. (2019) · International Journal of Urology · doi:10.1111/iju.13982 · Cited by 9
Outcomes after robot-assisted laparoscopic radical prostatectomy
Murphy, D. G., Challacombe, B. J., & Costello, A. J. (2008) · Asian Journal of Andrology · doi:10.1038/aja.2008.10 · Cited by 9
Postoperative radiotherapy for prostate cancer
Höcht, S., & Hinkelbein, W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67075-4 · Cited by 9
Screening for Prostate Cancer: Current Status and Future Prospects
Sharifi, N., & Kramer, B. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.12.014 · Cited by 9
Gilbert, S. M. (2008) · Cancer · doi:10.1002/cncr.23471 · Cited by 9
Adjuvant radiotherapy following radical prostatectomy for prostate cancer
Daly, T., Hickey, B. E., Lehman, M., & Francis, D. P. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007234 · Cited by 9
Ahlberg, M. S., Garmo, H., Adami, H., Andrén, O., Johansson, J., Steineck, G., Holmberg, L., & Bill‐Axelson, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057242 · Cited by 12
Self-citationHong, S. K., Oh, J. J., Jeong, S. J., Jeong, C. W., Kim, I. S., Park, J. M., Byun, S., Choe, G., Lee, H. J., & Lee, S. E. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09814.x · Cited by 8
Patient knowledge about prostate‐specific antigen (PSA) and prostate cancer in Australia
Pan, D., & McCahy, P. J. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11048.x · Cited by 8
Xiao, H., Tan, F., Goovaerts, P., Ali, A. A., Adunlin, G., Gwede, C. K., & Huang, Y. (2013) · American Journal of Men s Health · doi:10.1177/1557988313512862 · Cited by 8
Homogeneous Prostate Cancer Mortality in the Nordic Countries Over Four Decades
Meyer, M. S., Mucci, L. A., Andersson, S., Andrén, O., Johansson, J., Tretli, S., & Adami, H. (2010) · European Urology · doi:10.1016/j.eururo.2010.05.040 · Cited by 7
Self-citationRole of histopathology and molecular markers in the active surveillance of prostate cancer
Montironi, R., Egevad, L., Bjartell, A. S., & Berney, D. M. (2011) · Acta Oncologica · doi:10.3109/0284186x.2010.522199 · Cited by 8
Comparative effectiveness research in localized prostate cancer treatment
Hoffman, R. M., Penson, D. F., Zietman, A. L., & Barry, M. J. (2013) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.13.66 · Cited by 8
Gupta, N. P., Murugesan, A., Kumar, A. A., & Yadav, R. (2016) · Indian Journal of Urology · doi:10.4103/0970-1591.179187 · Cited by 8
New technique of inguinal hernia repair during prostatectomy
Talebpour, M., Khatami, F., Aghaii, M., & Aghamir, S. M. K. (2020) · Journal of Clinical Urology · doi:10.1177/2051415820961301 · Cited by 12
Rasouli, M. A., Moradi, G., Zareie, B., Sofimajidpour, H., Tozandehjani, S., Zafari, H., Gholami, F., Shahsavari, S., Hassani, P., & Mohammadian, M. (2021) · BMC Cancer · doi:10.1186/s12885-021-09078-8 · Cited by 8
Fischer-Valuck, B. W., Baumann, B. C., Brown, S. A., Filson, C. P., Weiss, A. D., Mueller, R., Liu, Y., Brenneman, R., Sanda, M. G., Michalski, J. M., et al. (2022) · European Urology Open Science · doi:10.1016/j.euros.2021.12.011 · Cited by 10
Kirby, R. S., & Kirby, M. G. (2005) · Urology · doi:10.1016/j.urology.2005.07.004 · Cited by 9
Lead Time of Prostate Cancer Detected in Population Based Screening for Prostate Cancer in Japan
Ito, K., Yamamoto, T., Miyakubo, M., Takechi, H., Ohi, M., Shibata, Y., & Suzuki, K. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.05.144 · Cited by 8
The spectrum of prostate cancer care: From curative intent to palliation
Ali, A., & Hamdy, F. C. (2007) · Current Urology Reports · doi:10.1007/s11934-007-0013-9 · Cited by 8
Wen, Y., Chen, W., Lee, W.-J., Yang, S., Lee, L.-M., & Chien, M. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.036 · Cited by 9
Prostate Cancer Testing following a Negative Prostate Biopsy: Over Testing the Elderly
Hoffman, R. M., Denberg, T. D., Hunt, W. C., & Hamilton, A. S. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0248-7 · Cited by 8
Kangmennaang, J., & Luginaah, I. (2016) · Journal of Cancer Epidemiology · doi:10.1155/2016/7284303 · Cited by 8
A Urologist’s Personal View of Prostate Cancer
Schellhammer, P. F. (2016) · Urology Research and Practice · doi:10.5152/tud.2016.50318 · Cited by 7
Prostate Cancer and the Increasing Role of Active Surveillance
Alonzo, D., Mure, A., & Soloway, M. S. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.09.2705 · Cited by 8
Prostate Cancer Treatment Patterns Among Racial/Ethnic Groups in Florida
Xiao, H., Warrick, C. A., & Huang, Y. (2009) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)31042-7 · Cited by 8
Should men over the age of 65 years receive PSA screening? Argument in favor
Whitson, J. M., & Konety, B. R. (2008) · Nature Clinical Practice Urology · doi:10.1038/ncpuro1078 · Cited by 8
Prostate Cancer – To screen, or not to screen, is that the question?
Rosser, C. J. (2008) · BMC Urology · doi:10.1186/1471-2490-8-20 · Cited by 8
Prostate Cancer: To Treat or Not to Treat?
Abrahamsson, P. (2009) · European Urology Supplements · doi:10.1016/j.eursup.2009.01.007 · Cited by 8
Incremental value of magnetic resonance imaging in the advanced management of prostate cancer
Wang, L. (2009) · World Journal of Radiology · doi:10.4329/wjr.v1.i1.3 · Cited by 8
Employment After Therapy for Localized Prostate Cancer: Widening the Perspective
Talcott, J. A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji182 · Cited by 8
Prostate Cancer Screening: The Need For Problem-Solving that Puts Men's Interests First
Holmberg, L. (2009) · European Urology · doi:10.1016/j.eururo.2009.04.026 · Cited by 8
Self-citationNanomedicines in diagnosis and treatment of prostate cancers: an updated review
Wang, J., Zhang, X., Xing, J., Gao, L., & Lu, H. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1444201 · Cited by 16
Rosin, R. D., Haynes, A., Kidd, M. S., Drozdov, I. A., Modlin, I. M., & Halim, A. B. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102642 · Cited by 7
Trends in Prostate Cancer Screening: Canada
Nam, R. K., & Klotz, L. H. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-281-0_3 · Cited by 7
Cryotherapy in prostate cancer
Phillips, J. M., Catarinicchia, S. P., Krughoff, K., & Barqawi, A. B. (2014) · Journal of Clinical Urology · doi:10.1177/2051415814521806 · Cited by 7
Comparative effectiveness research in urology
Wang, A. T., Wang, J. K., Montori, V. M., & Murad, M. H. (2010) · World Journal of Urology · doi:10.1007/s00345-010-0637-0 · Cited by 7
Etzioni, R., Durand‐Zaleski, I., & Lansdorp‐Vogelaar, I. (2013) · JNCI Monographs · doi:10.1093/jncimonographs/lgt010 · Cited by 7
Namiki, S., & Arai, Y. (2011) · Reproductive Medicine and Biology · doi:10.1007/s12522-011-0076-7 · Cited by 7
Circulating tumor cell assays for the prognosis of prostate and colon cancers
Davis, J. W. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050902791598 · Cited by 7
Stensvold, A., Dahl, A. A., Fosså, S. D., Axcrona, K., Lilleby, W. A., Brennhovd, B., & Smeland, S. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.492236 · Cited by 7
Novel multifunctional nanocarrier-mediated codelivery for targeting and treatment of prostate cancer
Arya, A. K., Ahmad, H., Khandelwal, K., Agrawal, S., & Dwivedi, A. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816505-8.00008-4 · Cited by 9
Modeling time resolved light propagation inside a realistic human head model.
Bazrafkan, S., & Kazemi, K. (2014) · PubMed Central · Cited by 7
Auperin, A., Laplanche, A., & Hill, C. (2007) · La Presse Médicale · doi:10.1016/j.lpm.2007.04.008 · Cited by 7
Survival associated with treatment vs. observation of localized prostate cancer in elderly men
Penson, D. F. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.08.001 · Cited by 7
Critical Review: Is Watchful Waiting a Viable Management Option for Older Men With Prostate Cancer?
Bailey, D. E., & Wallace, M. E. (2007) · American Journal of Men s Health · doi:10.1177/1557988306294161 · Cited by 7
Roberts, R. A. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2014.458 · Cited by 7
Sox, H. C., & Mulrow, C. D. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-3-200508020-00011 · Cited by 7
Radical prostatectomy vs watchful waiting
Kirby, R. S., & Fitzpatrick, J. M. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05795.x · Cited by 7
The Case for Prostate Cancer Screening with Prostate-Specific Antigen
Andriole, G. L., Djavan, B., Fleshner, N. E., & Schröder, F. H. (2006) · European Urology Supplements · doi:10.1016/j.eursup.2006.06.013 · Cited by 7
Berk, L. B. (1989) · PubMed · Cited by 7
Berg, A. S., Bruland, Ø. S., Fosså, S. D., Nesland, J. M., Berner, A., Schirmer, C. B., & Lilleby, W. A. (2008) · The Prostate · doi:10.1002/pros.20826 · Cited by 6
Ullevig, S. L., Bacich, D. J., Gutierrez, J. M., Balarin, A., Lobitz, C. A., O’Keefe, D. S., & Liss, M. A. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.06.004 · Cited by 6
Oh, M., McBride, A., Bhattacharjee, S., Slack, M. K., Jeter, J., & Abraham, I. L. (2023) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2023.2169137 · Cited by 6
Vickers, A. J. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0294 · Cited by 6
Doumerc, N., Yuen, C., Savdie, R., Rahman, M. B., Benito, R. P., & Stricker, P. D. (2010) · Journal of Robotic Surgery · doi:10.1007/s11701-010-0171-5 · Cited by 6
Dubovenko, A., Serebryiskaya, T., Nikolsky, Y., Nikolskaya, T., Perlina, A., JeBailey, L., Bureeva, S. V., Katta, S., Srivastava, S. K., Dobi, A., et al. (2015) · Journal of Cancer · doi:10.7150/jca.8213 · Cited by 6
Post-prostatectomy radiation therapy for locally recurrent prostate cancer
Isharwal, S., & Stephenson, A. J. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1378575 · Cited by 6
Ma, W., Poon, D. M. C., Chan, C.-K., Chan, T., Cheung, F., Ho, L., Lee, E. K., Leung, A. K., Leung, S. Y., So, H., et al. (2019) · British Journal of Urology · doi:10.1111/bju.14681 · Cited by 6
Design and synthesis of dye-conjugated hepsin inhibitors
Kim, K., Kwon, H., Choi, D., Lim, T., Minn, I., Son, S., & Byun, Y. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102990 · Cited by 6
Prostate cancer screening: Canadian guidelines 2011
Izawa, J. I., Klotz, L. H., Siemens, R. D., Kassouf, W., So, A., Jordan, J., CHETNER, M. P., & Iansavitchene, A. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.656 · Cited by 6
Metadata
- Authors
- Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., Palmgren, J., Adami, H.-O., Norlén, B. J., & Johansson, J.-E.
- Affiliations
- University of Helsinki (FI)
- Linköping University Hospital (SE)
- Uppsala University Hospital (SE)
- Karolinska Institutet (SE)
- Harvard University (US)
- Örebro University Hospital (SE)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-05-12
- Volume
- 352
- Issue
- 19
- Pages
- 1977-1984
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4233182856
- Cited by
- 1,111
- References
- 11
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 18 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 23 · 2018: 21 · 2017: 20 · 2016: 24 · 2015: 35 · 2014: 35 · 2013: 50 · 2012: 68
- FWCI
- 120.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- radical prostatectomy, expectant management, early-stage prostate cancer, prostate cancer mortality, distant metastasis, local tumor progression, all-cause mortality, long-term follow-up, surgical versus conservative treatment
- MeSH terms
- Aged, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Metastasis, Prostatectomy, Prostatic Neoplasms, Incidence, Proportional Hazards Models, Survival Analysis, Disease Progression, Antineoplastic Agents, Hormonal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.